| 000 | 01768 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516012501.0 | ||
| 264 | 0 | _c20110608 | |
| 008 | 201106s 0 0 eng d | ||
| 022 | _a1468-201X | ||
| 024 | 7 |
_a10.1136/hrt.2010.194654 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJie, Kim E | |
| 245 | 0 | 0 |
_aShort- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome. _h[electronic resource] |
| 260 |
_bHeart (British Cardiac Society) _cJan 2011 |
||
| 300 |
_a60-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnemia _xdrug therapy |
| 650 | 0 | 4 |
_aAntigens, CD34 _xmetabolism |
| 650 | 0 | 4 | _aCell Count |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aChemokine CXCL12 _xmetabolism |
| 650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aErythropoietin _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xblood |
| 650 | 0 | 4 |
_aHematinics _xtherapeutic use |
| 650 | 0 | 4 |
_aHemoglobins _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xblood |
| 650 | 0 | 4 | _aLong-Term Care |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aStem Cells _xdrug effects |
| 650 | 0 | 4 | _aSyndrome |
| 700 | 1 | _avan der Putten, Karien | |
| 700 | 1 | _aBergevoet, Marloes W T | |
| 700 | 1 | _aDoevendans, Pieter A | |
| 700 | 1 | _aGaillard, Carlo A J M | |
| 700 | 1 | _aBraam, Branko | |
| 700 | 1 | _aVerhaar, Marianne C | |
| 773 | 0 |
_tHeart (British Cardiac Society) _gvol. 97 _gno. 1 _gp. 60-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/hrt.2010.194654 _zAvailable from publisher's website |
| 999 |
_c20369331 _d20369331 |
||